Share-based Payment Arrangement, Expense of Bluejay Diagnostics, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Bluejay Diagnostics, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Bluejay Diagnostics, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $183, a 96% decline year-over-year.
  • Bluejay Diagnostics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $2,650, a 137% decline year-over-year.
  • Bluejay Diagnostics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $20,094, a 89% decline from 2023.
  • Bluejay Diagnostics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $189,245, a 56% decline from 2022.
  • Bluejay Diagnostics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $433,004, a 533% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Bluejay Diagnostics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,650 $183 -$4,609 -96% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $1,959 $1,563 -$7,573 -126% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $9,532 $1,312 -$10,562 -89% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $20,094 $2,582 +$12,982 +83% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 $7,112 $4,792 +$47,274 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025 2025 Q3
Q2 2024 $40,162 $6,010 -$21,692 -78% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $18,470 $11,874 -$207,715 -95% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 $189,245 $15,564 -$103,149 -118% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $292,394 $42,482 -$155,701 -138% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $448,095 $27,702 -$78,412 -74% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 $471,778 $219,589 +$93,503 +74% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q1 2023 $164,860 +$38,774 +31% 01 Feb 2023 28 Feb 2023 10-Q 09 Nov 2023 2023 Q3
Q4 2022 $433,004 $87,585 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $113,219 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $106,114 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $126,086 +$125,922 +76782% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q1 2021 $164 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1

Bluejay Diagnostics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $20,094 -$169,151 -89% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $189,245 -$243,759 -56% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $433,004 +$364,546 +533% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $68,458 +$61,088 +829% 01 Jan 2021 31 Dec 2021 10-K 20 Mar 2023 2022 FY
2020 $7,370 01 Jan 2020 31 Dec 2020 10-K 10 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.